The evaluation and treatment of androgen excess.
D000052:Acanthosis Nigricans / Q000150:complications / Q000503:physiopathology; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000307:Adrenal Gland Diseases / Q000150:complications; D000726:Androgen Antagonists / Q000627:therapeutic use; D000858:Anovulation / Q000209:etiology / Q000628:therapy; D004701:Endocrine Gland Neoplasms / Q000150:complications; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006628:Hirsutism / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D017588:Hyperandrogenism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D007333:Insulin Resistance; D011085:Polycystic Ovary Syndrome / Q000209:etiology / Q000601:surgery; D013577:Syndrome
D000305:Adrenal Cortex Hormones; D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone